Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01596751 |
Title | Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Hope Rugo, MD |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California, San Francisco | San Francisco | California | 94143 | United States | Details | |
Duke University Cancer Center | Durham | North Carolina | 27710 | United States | Details | |
Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | United States | Details |